TRANSCHEMPharmaceuticals
Transchem Ltd — Profit & Loss Statement
₹162.65
+1.96%
Transchem Ltd Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tax Effect Of Unusual Items | 0.13 Cr | -2564.30 | 65894.40 | -0.05 Cr | — |
| Tax Rate For Calcs | 0.26 | 0.26 | 0.26 | 0.26 | — |
| Normalized EBITDA | -1.96 Cr | -1.71 Cr | 2.49 Cr | 4.11 Cr | — |
| Total Unusual Items | 0.50 Cr | -10000.00 | 0.03 Cr | -0.20 Cr | — |
| Total Unusual Items Excluding Goodwill | 0.50 Cr | -10000.00 | 0.03 Cr | -0.20 Cr | — |
| Net Income From Continuing Operation Net Minority Interest | 5.23 Cr | 4.20 Cr | 1.24 Cr | 2.87 Cr | — |
| Reconciled Depreciation | 57000.00 | 81000.00 | 78000.00 | 78000.00 | — |
| Reconciled Cost Of Revenue | 3.03 Cr | 1.07 Cr | 0.71 Cr | 0.69 Cr | — |
| EBITDA | -1.46 Cr | -1.71 Cr | 2.51 Cr | 3.92 Cr | — |
| EBIT | -1.47 Cr | -1.72 Cr | 2.50 Cr | 3.91 Cr | — |
| Net Interest Income | 8.03 Cr | 7.37 Cr | 4.04 Cr | 5.45 Cr | — |
| Interest Income | 8.03 Cr | 7.37 Cr | 4.05 Cr | 5.45 Cr | — |
| Normalized Income | 4.86 Cr | 4.20 Cr | 1.22 Cr | 3.01 Cr | — |
| Net Income From Continuing And Discontinued Operation | 5.23 Cr | 4.20 Cr | 1.24 Cr | 2.87 Cr | — |
| Total Expenses | 4.10 Cr | 2.13 Cr | 1.74 Cr | 2.56 Cr | — |
| Rent Expense Supplemental | 0.01 Cr | 79000.00 | 79000.00 | 79000.00 | — |
| Diluted Average Shares | 1.22 Cr | 1.22 Cr | 1.22 Cr | 1.22 Cr | — |
| Basic Average Shares | 1.22 Cr | 1.22 Cr | 1.22 Cr | 1.22 Cr | — |
| Diluted EPS | 4.27 | 3.43 | 1.01 | 2.34 | — |
| Basic EPS | 4.27 | 3.43 | 1.01 | 2.34 | — |
| Diluted NI Availto Com Stockholders | 5.23 Cr | 4.20 Cr | 1.24 Cr | 2.87 Cr | — |
| Net Income Common Stockholders | 5.23 Cr | 4.20 Cr | 1.24 Cr | 2.87 Cr | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | 5.23 Cr | 4.20 Cr | 1.24 Cr | 2.87 Cr | — |
| Net Income Including Noncontrolling Interests | 5.23 Cr | 4.20 Cr | 1.24 Cr | 2.87 Cr | — |
| Net Income Continuous Operations | 5.23 Cr | 4.20 Cr | 1.24 Cr | 2.87 Cr | — |
| Tax Provision | 1.84 Cr | 1.45 Cr | 1.27 Cr | 1.04 Cr | — |
| Pretax Income | 7.06 Cr | 5.65 Cr | 2.50 Cr | 3.91 Cr | — |
| Other Non Operating Income Expenses | 8.53 Cr | 7.40 Cr | 0.17 Cr | 1.19 Cr | — |
| Special Income Charges | 0.50 Cr | -10000.00 | 0.00 | -0.20 Cr | — |
| Other Special Charges | -0.50 Cr | — | — | — | -22.46 Cr |
| Write Off | 0.00 | 10000.00 | 0.00 | 0.20 Cr | — |
| Net Non Operating Interest Income Expense | 8.03 Cr | 7.37 Cr | 4.04 Cr | 5.45 Cr | — |
| Interest Income Non Operating | 8.03 Cr | 7.37 Cr | 4.05 Cr | 5.45 Cr | — |
| Operating Income | -1.47 Cr | -1.72 Cr | -1.74 Cr | -2.56 Cr | — |
| Operating Expense | 1.07 Cr | 1.06 Cr | 1.03 Cr | 1.87 Cr | — |
| Other Operating Expenses | 0.34 Cr | 0.20 Cr | 0.18 Cr | 0.17 Cr | — |
| Depreciation And Amortization In Income Statement | 57000.00 | 81000.00 | 78000.00 | 78000.00 | — |
| Depreciation Income Statement | 57000.00 | 81000.00 | 78000.00 | 78000.00 | — |
| Selling General And Administration | 0.46 Cr | 0.61 Cr | 0.62 Cr | 1.52 Cr | — |
| Selling And Marketing Expense | 35000.00 | 26000.00 | 26000.00 | 28000.00 | — |
| General And Administrative Expense | 0.46 Cr | 0.61 Cr | 0.62 Cr | 1.52 Cr | — |
| Rent And Landing Fees | 0.01 Cr | 79000.00 | 79000.00 | 79000.00 | — |
| Gross Profit | -0.40 Cr | -0.66 Cr | -0.71 Cr | -0.69 Cr | — |
| Cost Of Revenue | 3.03 Cr | 1.07 Cr | 0.71 Cr | 0.69 Cr | — |
| Total Revenue | 2.63 Cr | 0.41 Cr | 0.00 | 0.00 | — |
| Operating Revenue | 2.63 Cr | 0.41 Cr | 0.00 | 0.00 | — |
| Interest Expense | — | 0.00 | 3000.00 | 1000.00 | 13000.00 |
| Total Other Finance Cost | — | 1000.00 | 3000.00 | — | 354.00 |
| Interest Expense Non Operating | — | 0.00 | 3000.00 | 1000.00 | 13000.00 |
| Research And Development | — | — | — | 0.00 | 0.21 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Transchem Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.